Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 14 Jul 2024
Reviewer:  Mohamed Hashim
Reviewer's report:
There are some limitations that are acknowledged by the authors.  Small sample size,
retrospective nature of the study, lack of control group.
In the method section: Aetiology of liver disease should be mentioned and its relation to survival.
Milan and Hangzhou criteria should be explained.
What is about other factors affecting survival post transplant such as type of
immunosuppression, .........
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 14 Jul 2024
Reviewer:  Mohamed Hashim
Reviewer's report:
There are some limitations that are acknowledged by the authors.  Small sample size,
retrospective nature of the study, lack of control group.
In the method section: Aetiology of liver disease should be mentioned and its relation to survival.
Milan and Hangzhou criteria should be explained.
What is about other factors affecting survival post transplant such as type of
immunosuppression, .........
Please review this paper.
user
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 14 Jul 2024
Reviewer:  Mohamed Hashim
Reviewer's report:
There are some limitations that are acknowledged by the authors.  Small sample size,
retrospective nature of the study, lack of control group.
In the method section: Aetiology of liver disease should be mentioned and its relation to survival.
Milan and Hangzhou criteria should be explained.
What is about other factors affecting survival post transplant such as type of
immunosuppression, .........
assistant